Current Roles

Employees:
37
Revenue:
$3.8M
About
Founded in March, 2009, TAXIS Pharmaceuticals is focused on the discovery and development of pharmaceuticals targeting multidrug-resistant bacterial pathogens that constitute a worldwide therapeutic category estimated to exceed $30B in annual sales revenues. The initial series of proprietary lead candidates, referred to as the azachryseniums (AZCs), display in vitro activity that is superior to current standards of care for a broad range of Gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
TAXIS Pharmaceutical Address
9 Deer Park Drive,
null, null
TAXIS Pharmaceutical Email

Past Companies

TAXIS Pharmaceuticals, Inc.CEO
Evogen, Inc.Board Chairman
MFPPartner

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.